Director
DIN: 10454451
Sumanlatha Nuthalapati is currently associated with 2 companies as Director. They serve as a Director at SCUDDER LIFE SCIENCES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10454451.Sumanlatha Nuthalapati has previously been associated with 1 company in roles such as Additional Director.Sumanlatha Nuthalapati is currently involved in 1 different role. Their most recent position is with LESA THERAPEUTICS PRIVATE LIMITED as a Director. The first company Sumanlatha Nuthalapati was appointed to as a director was SCUDDER LIFE SCIENCES PRIVATE LIMITED. Sumanlatha Nuthalapati is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sumanlatha Nuthalapati is currently associated with 2 companies as Director. They serve as a Director at SCUDDER LIFE SCIENCES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10454451.Sumanlatha Nuthalapati has previously been associated with 1 company in roles such as Additional Director.Sumanlatha Nuthalapati is currently involved in 1 different role. Their most recent position is with LESA THERAPEUTICS PRIVATE LIMITED as a Director. The first company Sumanlatha Nuthalapati was appointed to as a director was SCUDDER LIFE SCIENCES PRIVATE LIMITED. Sumanlatha Nuthalapati is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
6 Months 3 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SCUDDER LIFE SCIENCES PRIVATE LIMITED | Director | 30-Sep-2024 |
| LESA THERAPEUTICS PRIVATE LIMITED | Director | 28-Apr-2026 |